The Imaging, Innovative Radiotherapy, and Systems Medicine Laboratory (IRIS), supported by Inserm, CNRS, Institut Curie, and the University of Versailles Saint-Quentin (U1353 / UMR XXXX), was established on January 1st, 2026, as the successor to the Laboratory of Translational Imaging in Oncology (Welcome - LITO).

The laboratory is composed of four teams with highly complementary research activities:

  • Cancer Imaging and its Ecosystem (ICE)

  • Molecular Pathology and Preclinical Testing (IMPACT)

  • Innovative Radiotherapy (ATOMIC)

  • Integrative Radiomics (RADIOME)

IRIS includes approximately 70 researchers, engineers, physicians, pharmacists, technicians, PhD students, and postdoctoral fellows, spread across the three sites of Institut Curie: the Research Center (Orsay), and the Departments of Imaging and Pharmacology at the Hospital sites in Saint-Cloud and Paris.